Patents
Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
10/2006
10/19/2006US20060235233 Precipitating a metal compound (especially a titanate) from a solution of a linear (and optionally a macrocyclic) polyester oligomer by heating to at least 200 degrees C. for at least 5 minutes; oligomer solutioncan be polymerized and then depolymerized (cyclized) to form macrocyclic polyester oligomer
10/18/2006CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/10/2006CA2262617C Nitrification inhibitors and the use of polyacids to treat mineral fertilizers containing a nitrification inhibitor
10/05/2006US20060224023 Ketene dithioketals used to make alkylbis(alkylthio)carbenium ; liquid-crystalline compounds
10/04/2006EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
10/04/2006CN1277830C Para-herqueinamide as medicine for resisting parasite
10/03/2006US7115757 1,2-dioxetane derivatives and reagents employing them
09/2006
09/26/2006US7112685 Labeled resiniferatoxin derivatives
09/21/2006WO2006098308A1 Novel anthranilic acid derivative or salt thereof
09/21/2006US20060211872 Method for the production of trimeric ketone peroxide solutions
09/21/2006CA2602609A1 Novel anthranilic acid derivative or salt thereof
09/20/2006EP0889889B1 Piperazine and piperidine compounds
09/14/2006WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
09/14/2006CA2600674A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
09/13/2006EP1054011B1 Novel antifungal compounds and process for producing the same
09/12/2006US7105708 Method for producing compounds having a CF2O bridge
09/08/2006WO2006092623A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
09/08/2006CA2598785A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
09/06/2006EP1696907A1 Pdk-1/akt signaling inhibitors
08/2006
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/30/2006CN1826106A Chromatosis remedies
08/24/2006WO2006004774A3 Laulimalide analogues as therapeutic agents
08/23/2006CN1823053A 1,2,4,-trioxepanes as precursors for lactones
08/22/2006US7094896 Diaminothiazoles having antiproliferative activity
08/22/2006US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets
08/16/2006EP1689716A1 Biaryl sulfonamides and methods for using same
08/16/2006EP1689380A2 Method for treating adamts-5-associated disease
08/15/2006US7091338 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity
08/10/2006WO2006081771A1 Artemisine (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same
08/10/2006US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease
08/09/2006EP1687291A2 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
08/09/2006EP1686947A2 Method for the production of bioactive substances from the novel actinomycete taxon mar2 (marinophilus)
08/09/2006CN1814601A Artemisine derivative with immune suppression action and medicinal composition
08/03/2006WO2005060456A8 Method for treating adamts-5-associate disease
08/03/2006US20060173058 Kcnq channel modulating compounds and their pharmaceutical use
08/03/2006US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension
07/2006
07/27/2006US20060167281 1,2,4- Trioxepanes as precursors for lactones
07/26/2006EP1682528A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES
07/19/2006EP1325054B1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
07/18/2006US7078540 Substituted aromatic-ring compounds, process for producing the same, and use
07/18/2006CA2341890C Oxygen-containing heterocyclic compounds
07/13/2006CA2592900A1 Nitrogen containing bicyclic compounds and therapeutical use thereof
07/12/2006CN1263762C Desugar and deaminosugar FR-008 derived polyketone antibiotics
07/04/2006US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives
07/04/2006US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation
06/2006
06/29/2006WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/29/2006US20060142377 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma
06/29/2006CA2591208A1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
06/28/2006EP1674439A1 Process for producing a-methylstyrene
06/28/2006CN1261436C Bibenzil compound 13,13'-O-iso-propylidene riccardia D and its extraction and separation method and use
06/21/2006EP1671965A2 Oxacarbocyclic oligomers of fumaric acid
06/15/2006WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation
06/15/2006CA2587928A1 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
06/07/2006EP1664013A1 Calcilytic compounds
06/06/2006US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency
05/2006
05/30/2006US7053208 Dioxetane probes for use as signaling tool in biological analysis
05/25/2006US20060111270 Ketocampholenic acid derivatives and their use in fragrance applications
05/17/2006CN1256335C Ketal intermediate obtained from preparation of trion-bis(oxime ether) derivatives
04/2006
04/26/2006EP1649852A1 Chromatosis remedies
04/19/2006EP1646618A1 1,2,4,-trioxepanes as precursors for lactones
04/19/2006CN1252029C Water soluble tri-substituted 1, 2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
04/13/2006DE102004049056A1 Verfahren zur Herstellung und Reinigung von zyklischen Formalen A process for the preparation and purification of cyclic formals
04/13/2006DE102004049055A1 Verfahren zur Herstellung und Reinigung von zyklischen Formalen A process for the preparation and purification of cyclic formals
04/12/2006EP1039897B1 Inadone and tetralone compounds for inhibiting cell proliferation
04/06/2006US20060074119 Thiophene compounds
04/06/2006CA2581375A1 Specific kinase inhibitors
04/05/2006EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
04/04/2006US7022664 1,2 Substituted 2,3-dihydro-1H-5,9 dioxacyclohepta[F]indden-7-ones and 7-substituted benzo[B][1,4]dioxepin-3-ones
04/04/2006CA2231199C 1,2 chemiluminescent dioxetanes of improved performance
03/2006
03/28/2006US7019149 Thromboxane ligands without blood clotting side effects
03/28/2006US7019003 Bactericides
03/21/2006US7015339 Washing the aqueous plant extract with a solvent, adjusting the pH from 10 to less 9, solvent extration of flavonoids
03/21/2006CA2238986C Compounds with isocyanate groups and masked groups reactive in relation to isocyanates
03/16/2006US20060058372 N-Benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarboxamide derivatives and pharmaceutical compositions comprising them
03/15/2006CN1245381C Phenylglycine derivatives
03/01/2006CN1740176A Process of extracting and separating artemisinin from sweet wormwood plant
02/2006
02/23/2006US20060041008 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
02/21/2006CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors
01/2006
01/26/2006WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
01/19/2006WO2006007436A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
01/19/2006WO2006007435A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
01/19/2006WO2005062811A3 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates
01/19/2006CA2570614A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
01/05/2006US20060004066 Method for treating ADAMTS-5-associated disease
01/04/2006EP1363873A4 Peptide deformylase inhibitors
12/2005
12/29/2005US20050288518 fragrance compositions for marine scented woman's fragrance
12/22/2005US20050282887 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
12/15/2005WO2005117849A1 Diarylalkanes as potent inhibitors of binuclear enzymes
12/15/2005CA2567801A1 Diarylalkanes as potent inhibitors of binuclear enzymes
12/14/2005EP1604987A2 Shaping of macrocyclic oligoesters
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005CN1708491A N-benzodioxolyl, N-benzodioxanyl and N-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
12/08/2005WO2005116007A1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues
12/08/2005WO2005115972A1 Therapeutic compounds
12/08/2005CA2767376A1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues
12/08/2005CA2565066A1 Therapeutic compounds
12/08/2005CA2563931A1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267094 glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 21